ALEXIS MONDELLA: Open Payments
NPI 1417400177 · QUEENSBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,238 in 79 payments from 15 companies in 2025. Trend: 2023 $175 · 2024 $916 · 2025 $2,238
Food & beverage: $2,238
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 11 | $378 |
| Alkermes, Inc. | 5 | $344 |
| E.R. Squibb & Sons, L.L.C. | 6 | $277 |
| Axsome Therapeutics, Inc. | 13 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $241 |
| Neurocrine BioSciences, Inc. | 8 | $157 |
| Otsuka America Pharmaceutical, Inc. | 9 | $141 |
| Lundbeck LLC | 6 | $123 |
| ABBVIE INC. | 3 | $112 |
| Novo Nordisk Inc | 3 | $57 |
Products named: SPRAVATO, COBENFY, ARISTADA, CAPLYTA, Auvelity, REXULTI, INGREZZA, QULIPTA.
Industry payments across NY — which companies pay providers there.
